• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
YAO Lei, QU Linlin, FAN Daidi. Effects of rare ginsenoside on idiopathic pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2023, 54(5): 607-613. DOI: 10.11665/j.issn.1000-5048.2023042002
Citation: YAO Lei, QU Linlin, FAN Daidi. Effects of rare ginsenoside on idiopathic pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2023, 54(5): 607-613. DOI: 10.11665/j.issn.1000-5048.2023042002

Effects of rare ginsenoside on idiopathic pulmonary fibrosis

Funds: This study was supported by the National Key Research and Development Program of China (No.2021YFC2101500), and Key Research and Development Program of Shaanxi Province (No.2022ZDLSF05-12)
More Information
  • Received Date: April 19, 2023
  • Revised Date: September 17, 2023
  • To investigate whether rare ginsenosides could alleviate idiopathic pulmonary fibrosis (IPF), C57BL/6 mice were randomly divided into control group, bleomycin (BLM)-induced IPF group, rare ginsenoside Rk1 group, rare ginsenoside Rk3 group, rare ginsenoside Rh4 group and rare ginsenoside Rg5 group.All mice except those in the control group were given bleomycin injection.The IPF model was established by BLM for 28 days.The treatment group was given ginsenoside intragastrically at the same time.After the experiment, the lung tissues of mice were collected and the pathological changes of the mice lungs were observed.The content of hydroxyproline (HYP) in mouse lung tissue was measured.The expression of IPF-related genes in mouse lung tissues was detected.In in vitro experiments, Medical Research Council cell strain-5 (MRC-5) was used to induce IPF cell model using transforming growth factor-β1 (10 ng/mL).The effects of four saponins on the expression of IPF-related genes were analyzed by MTT assay, HYP content determination and RT-qPCR.All four rare ginsenosides could effectively alleviate the pathological process such as alveolar structure destruction caused by IPF, reduce the content of HYP, and down-regulate the expression of IPF-related genes, indicating that rare ginsenosides can effectively alleviate IPF.
  • [1]
    Xie WN, Ding Q, Sun J, et al. Protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice[J]. J China Pharm Univ (中国药科大学学报), 2018, 49(4): 483-489.
    [2]
    Steele MP, Schwartz DA. Molecular mechanisms in progressive idiopathic pulmonary fibrosis[J]. Annu Rev Med, 2013, 64: 265-276.
    [3]
    Miao Y, Wang YH, Bi Z, et al. Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice[J]. BMC Pulm Med, 2023, 23(1): 94.
    [4]
    Xiang J, Yu P, Li MD, et al. Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis[J]. J China Pharm Univ (中国药科大学学报), 2017, 48(1): 76-81.
    [5]
    Prasse A, Probst C, Bargagli E, et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2009, 179(8): 717-723.
    [6]
    Wang J, Xu LZ, Xiang Z, et al. Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206+ M2-like macrophage polarization[J]. Cell Death Dis, 2020, 11(2): 136.
    [7]
    Zhang SN, Li LQ, Zhang HC, et al. Clinical study on treating idiopathic pulmonary fibrosis with TCM method of invigorating Qi, moisturizing the lung and removing blood stasis and toxic substance[J].J Beijing Univ Tradit Chin Med (北京中医药大学学报), 1999, 22(3): 57-60.
    [8]
    Kang A, Zhang SJ, Shan JJ, et al. Pharmacokinetics of ginsenoside Rb1 in lincomycin-induced gut microbiota dysbiosis rats[J]. J China Pharm Univ (中国药科大学学报), 2016, 47(2): 182-187.
    [9]
    Wu W, Jiao CX, Li H, et al. LC-MS based metabolic and metabonomic studies of Panax ginseng[J]. Phytochem Anal, 2018, 29(4): 331-340.
    [10]
    Liang Y, Zhao S. Progress in understanding of ginsenoside biosynthesis[J]. Plant Biol, 2008, 10(4): 415-421.
    [11]
    Zhu MR, Yang CL. Blue fluorescent emitters: design tactics and applications in organic light-emitting diodes[J]. Chem Soc Rev, 2013, 42(12): 4963-4976.
    [12]
    Wang CZ, Aung HH, Ni M, et al. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots[J]. Planta Med, 2007, 73(7): 669-674.
    [13]
    Jin X, Zhu LY, Shen H, et al. Influence of sulphur-fumigation on the quality of white ginseng: a quantitative evaluation of major ginsenosides by high performance liquid chromatography[J]. Food Chem, 2012, 135(3): 1141-1147.
    [14]
    Pan WL, Xue BL, Yang CL, et al. Biopharmaceutical characters and bioavailability improving strategies of ginsenosides[J]. Fitoterapia, 2018, 129: 272-282.
    [15]
    Yu T, Rhee MH, Lee J, et al. Ginsenoside rc from Korean red ginseng (Panax ginseng C.A. Meyer) attenuates inflammatory symptoms of gastritis, hepatitis and arthritis[J]. Am J Chin Med, 2016, 44(3): 595-615.
    [16]
    Leung KW, Pon YL, Wong RN, et al. Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factor-dependent pathway in human endothelial cells[J]. J Biol Chem, 2006, 281(47): 36280-36288.
    [17]
    Bai X, Fu RZ, Duan ZG, et al. Ginsenoside Rh4 alleviates antibiotic-induced intestinal inflammation by regulating the TLR4-MyD88-MAPK pathway and gut microbiota composition[J]. Food Funct, 2021, 12(7): 2874-2885.
    [18]
    Guan SB, Yu P, Cao JH, et al. Ginsenoside Rg1 protects against cigarette smoke-induced airway remodeling by suppressing the TGF-β1/Smad3 signaling pathway[J]. Am J Transl Res, 2020, 12(2): 493-506.
    [19]
    Zeng DF, Wang JL, Kong PY, et al. Ginsenoside Rg3 inhibits HIF-1α and VEGF expression in patient with acute leukemia via inhibiting the activation of PI3K/Akt and ERK1/2 pathways[J]. Int J Clin Exp Pathol, 2014, 7(5): 2172-2178.
    [20]
    Liu Q, Kou JP, Yu BY. Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation[J]. Neurochem Int, 2011, 58(1): 119-125.
    [21]
    Guo CY, Zhang C, Xia ZM, et al. Nano-designed CO donor ameliorates bleomycin-induced pulmonary fibrosis via macrophage manipulation[J]. J Control Release, 2022, 341: 566-577.
    [22]
    Ciccolo JT, Carr LJ, Krupel KL, et al. The role of resistance training in the prevention and treatment of chronic disease[J]. Am J Lifestyle Med, 2010, 4(4): 293-308.
    [23]
    Yang K, Palm J, K?nig J, et al. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury[J]. Int J Radiat Biol, 2007, 83(10): 665-676.
    [24]
    José RJ, Williams AE, Chambers RC. Proteinase-activated receptors in fibroproliferative lung disease[J]. Thorax, 2014, 69(2): 190-192.
    [25]
    Betensley A, Sharif R, Karamichos D. A systematic review of the role of dysfunctional wound healing in the pathogenesis and treatment of idiopathic pulmonary fibrosis[J]. J Clin Med, 2016, 6(1): 2.
    [26]
    Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival[J]. Am J Respir Crit Care Med,1998,157(4 Pt 1):1063-1072.
  • Related Articles

    [1]QIAN Xiuhui, SUN Jing, FU San, TANG Xiaoyan, XU Xianghong, ZHANG Mian. Effect of intratracheal instillation of PM2.5 suspensionon pulmonary fibrosis in mice and the intervention of neotuberostemonine[J]. Journal of China Pharmaceutical University, 2021, 52(4): 455-462. DOI: 10.11665/j.issn.1000-5048.20210408
    [2]CAI Yanfei, WAN Aini, CHEN Yun, JIN Jian. Anti-liver fibrosis activities of the extracellular domain of transforming growth factor beta type II receptor fusion protein in vivo[J]. Journal of China Pharmaceutical University, 2019, 50(2): 246-252. DOI: 10.11665/j.issn.1000-5048.20190217
    [3]XIE Weina, DING Qi, SUN Jing, ZHANG Chaofeng, ZHANG Mian, XU Xianghong. Protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice[J]. Journal of China Pharmaceutical University, 2018, 49(4): 483-489. DOI: 10.11665/j.issn.1000-5048.20180415
    [4]WAN Aini, XU Dongsheng, CAI Yanfei, CHEN Yun, JIN Jian, LI Huazhong. Anti-liver fibrosis activities of human insulin-like growth factor-1 in vitro[J]. Journal of China Pharmaceutical University, 2017, 48(4): 476-482. DOI: 10.11665/j.issn.1000-5048.20170413
    [5]XIANG Juan, YU Ping, LI Mingdan, ZHANG Chaofeng, XU Xianghong, ZHANG Mian. Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2017, 48(1): 76-81. DOI: 10.11665/j.issn.1000-5048.20170112
    [6]ZENG Yi, ZHAO Cheng, WANG Fei, ZHU Qiuyan, XU Xiaole. Effects and mechanisms of stilbene glucoside on the proliferation and collagen synthesis of cardiac fibroblasts stimulated by TGF-β1[J]. Journal of China Pharmaceutical University, 2014, 45(3): 362-367. DOI: 10.11665/j.issn.1000-5048.20140320
    [7]Effect of Lovastatin on the Expression of Insulin-like Growth Factor-1 in the Cultured Human Mesangial Cells[J]. Journal of China Pharmaceutical University, 2003, (6): 43-47.
    [8]Expression of Human Transforming Growth Factor β3 in E.coli BL21[J]. Journal of China Pharmaceutical University, 2003, (3): 70-73.
    [9]Influence of Irbesartan on the Expression of Connective Tissue Growth Factor in Streptozotocin Induced Diabetic Rats[J]. Journal of China Pharmaceutical University, 2002, (4): 64-68.
  • Cited by

    Periodical cited type(4)

    1. 朱梦婷,刘志航,李航,林杏华,童晓萍,吴蕾,林琳,陈远彬. 基于R语言数据挖掘间质性肺病(肺痹)的古代源流与方药规律. 辽宁中医药大学学报. 2025(01): 215-220 .
    2. 刘碟碟,刘晓明,李芮. 基于网络药理学探讨人参-虎杖治疗特发性肺间质纤维化作用机制. 山西中医. 2024(08): 61-65 .
    3. 石耀楠,王雪慧. 中药单体干预博来霉素诱导肺纤维化动物模型相关调控机制研究进展. 老年医学研究. 2024(04): 64-68 .
    4. 张海莹,王淑冰,敖选丽,刘倩如,何怡霖,赏宇,陈兴龙,张文平,毛晓健,王亭,张荣平,侯博. 烤制、蒸制三七中皂苷类成分的化学模式识别及定量测定. 中草药. 2024(23): 7979-7988 .

    Other cited types(3)

Catalog

    Article views (135) PDF downloads (243) Cited by(7)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return